4
May 23
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye Agilent Technologies Inc. (NYSE: A) announced today that Dr. Jiangbin...
Read More
10
Mar 23
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023 Agilent Technologies Inc. (NYSE: A) announced today a highly anticipated...
Read More
16
Oct 22
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market Melbourne (Australia) – 17 October 2022. Telix...
Read More
19
Jul 22
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award Agilent Technologies Inc. (NYSE: A) today announced the company’s Certified Pre-Owned Instruments...
Read More
5
Apr 22
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma Agilent Technologies Inc....
Read More
5
Apr 22
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC) Agilent Technologies Inc....
Read More
7
Jan 22
The Innovators 2021
The Innovators 2021 R-TRACKER: A TRUE MILESTONE IN SPECIMEN TRACEABILITY Traceability is of paramount importance for patient safety...
Read More
2
Nov 21
Agilent Names John Palma to Lead Global Medical Affairs Organization
Agilent Names John Palma to Lead Global Medical Affairs Organization Agilent Technologies, Inc. (NYSE: A) today announced that John Palma...
Read More
21
Oct 21
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction,...
Read More
13
Oct 21
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer Agilent Technologies Inc. (NYSE:...
Read More
